High materiality7/10
H.C. Wainwright Reiterates Buy Rating on Monte Rosa Therapeutics (GLUE)
Why it may matterVerify against the original reporting
Upside potential as price remains well below target
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Analyst target update: Raymond James reiterates Buy on GLUE; Target $25; Posted price $10.5; priceChangeSinceSignal -2.19%.
- Analyst target update: Buy reiterated; Target $25; current price $10.5; priceSinceSignal -2.19%.
Key facts
- 01
Target: $25
- 02
Posted price: $10.5
- 03
Analyst firm: Raymond James
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.